Clarissa Desjardins insider trades

Open-market stock purchases and sales by Clarissa Desjardins, Director at INSMED Inc, from SEC Form 4 filings since Nov 12, 2019.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +41%.

Recent trades

DateStockTradeValue
May 13, 2026INSM INSMED IncBought (not open market)—

Companies traded

  • INSM INSMED Inc: 2 buys, last May 13, 2026
  • XENE Xenon Pharmaceuticals Inc: other filings, last Jun 1, 2020

Get free alerts when Clarissa Desjardins files a new trade →